Highlights from MSKCC’s 2024 Updates in Thrombosis and Hemostasis from Yan Leyfman
The MSKCC’s 2024 Updates in Thrombosis and Hemostasis symposium took place on October 27, 2024, at the Zuckerman Research Center in New York.
The event covered a range of specialities including Emergency Medicine, Hematology, Hematopathology, Hospitalist, Internal Medicine, Interventional Radiology, and Oncology/Hematology.
The symposium aimed to provide the latest insights in benign hematology, particularly focusing on:
- Current challenges in Venous Thromboembolism (VTE)
- Novel anticoagulants
- Thrombotic complications associated with clonal disorders
On this occasion, Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared some posts on LinkedIn:
The latest approaches to intervention from Jodi Mones
“Great presentation about the nuts and bolts of hematological complications of check point inhibitors including the latest approaches to intervention from Global Leader Dr. Jodi Mones from Memorial Sloan Kettering Cancer Center at MSKCC’s 2024 Updates in Thrombosis and Hemostasis.”
Diagnosis and management of thrombotic risk in MPN from Raajit Rampal
“Great discussion about the diagnosis and management of thrombotic risk in MPN from Global Leader Dr. Raajit Rampal of Memorial Sloan Kettering Cancer Center at MSKCC’s 2024 Updates in Thrombosis and Hemostasis.”
Management of PNH from Rekha Parameswaran
“Phenomenal overview of the management of PNH from Global Leader Dr. Rekha Parameswaran of Memorial Sloan Kettering Cancer Center at MSKCC’s 2024 Updates in Thrombosis and Hemostasis.”
Round-table case discussion led by Kuo-Kai Chin
“An engaging round-table case discussion led by rising oncology Dr. Kuo-Kai Chin of Memorial Sloan Kettering Cancer Center at MSKCC’s 2024 Updates in Thrombosis and Hemostasis.”
More posts featuring Yan Leyfman.
Yan Leyfman MD, is the Co-founder and executive director of MedNews Week. He is also the Medical correspondent at OncLive. He is also the Executive Committee Member at Music Beats Cancer. He is a Clinical Researcher at Icahn School of Medicine at Mount Sinai. His research interests include oncology, Immunooncology, Cellular Therapy, and Immunotherapy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023